Triple combination therapy shows promise against a rare, deadly asbestos cancer
Combining immune-boosting drugs with radiation and surgery increased the survival and anticancer immune response in mouse models of mesothelioma in preclinical research by Princess Margaret Cancer Centre researchers.
